Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Liaoning Oxiranchem,Inc. (300082.SZ)
Liaoyang, CN
Liaoning Oxiranchem, Inc. is a prominent Chinese enterprise whose core business revolves around the development, manufacturing, and distribution of sophisticated chemical products, specifically those derived from ethylene oxide. The company's product portfolio is diverse, featuring specialized solutions such as crystalline silicon cutting liquids essential for the photovoltaic industry, along with water-reducing agents vital for cement production. It also produces polyether monomers, ethylene carbonate, and polyethylene glycol (PEG). PEG, in particular, finds extensive utility across various sectors, including pharmaceuticals, personal care products, bio-based surfactants, advanced materials, and as specialized additives. Beyond these specific applications, Liaoning Oxiranchem's chemicals underpin a vast array of industries. They are integral to major infrastructure developments like high-speed rail networks, subway systems, airports, and expressways. Furthermore, their compounds are crucial in the formulation of cleaning agents, washing powders, pharmaceuticals, electronic components, automotive parts, textiles, printing inks, and dyes. Established in 2000, the company maintains its headquarters in Liaoyang, China, and operates as a subsidiary under the umbrella of Oxiranchem Holding Group Co., Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.35% | -7.27% | +8.30% | +18.95% | -6.82% | +17.27% | +81.12% | +44.94% | +22.60% | +104.40% | -60.58% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-1.4% Q1'26: +13.7% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+104.4% ★ Q1'26: +162.5% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-9.5% Q1'26: -23.2% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+2.2% Q1'26: +1.8% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+1.8% Q1'26: +1.8% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-1.8% ★ Q1'26: +0.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×6.43× Q1'26: 26.44× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
7.45B
est: 7.73B (-3.7%)
|
6.39B
est: 6.11B (+4.6%)
|
5.71B
est: 6.01B (-5.1%)
|
6.79B
est.
|
6.72B
est: 5.64B (+19.1%)
|
3.81B
est: 6.45B (-40.9%)
|
5.64B
est: 6.45B (-12.6%)
|
4.29B
est: 3.96B (+8.3%)
|
4.23B
est: 4.46B (-5.2%)
|
4.73B
4.73B – 4.73B
+6.0% YoY
|
5.10B
5.10B – 5.10B
+8.0% YoY
|
| EBITDA |
706.05M
est: 482.22M (+46.4%)
|
732.43M
est: 380.84M (+92.3%)
|
776.63M
est: 375.00M (+107.1%)
|
423.61M
est.
|
706.56M
est: 351.59M (+101.0%)
|
-35.65M
est: 402.16M (-108.9%)
|
331.04M
est: 402.16M (-17.7%)
|
91.80M
est: 190.58M (-51.8%)
|
273.56M
est: 214.60M (+27.5%)
|
227.50M
227.50M – 227.50M
+6.0% YoY
|
245.70M
245.70M – 245.70M
+8.0% YoY
|
| EBIT |
488.55M
est: 76.01M (+542.7%)
|
498.39M
est: 60.03M (+730.2%)
|
545.63M
est: 59.11M (+823.1%)
|
66.77M
est.
|
469.24M
est: 55.42M (+746.7%)
|
-299.65M
est: 63.39M (-572.7%)
|
78.80M
est: 63.39M (+24.3%)
|
-114.65M
est: 114.5K (-100,268.6%)
|
91.49M
est: 128.9K (+70,890.2%)
|
136.6K
136.6K – 136.6K
+6.0% YoY
|
147.6K
147.6K – 147.6K
+8.0% YoY
|
| Net Income |
325.69M
est: 332.33M (-2.0%)
|
352.06M
est: 339.25M (+3.8%)
|
402.73M
est: 406.18M (-0.9%)
|
380.79M
est.
|
352.24M
est: 6.92M (+4,987.6%)
|
-308.93M
est: -207.70M (-48.7%)
|
5.60M
est: -207.70M (+102.7%)
|
-159.24M
est: 13.59M (-1,271.4%)
|
6.80M
est: 6.80M (+0.0%)
|
40.78M
40.78M – 40.78M
+500.0% YoY
|
47.58M
47.58M – 47.58M
+16.7% YoY
|
| SGA |
213.44M
est: 109.74M (+94.5%)
|
238.00M
est: 86.67M (+174.6%)
|
147.82M
est: 85.34M (+73.2%)
|
96.40M
est.
|
182.65M
est: 80.01M (+128.3%)
|
172.27M
est: 91.52M (+88.2%)
|
157.39M
est: 91.52M (+72.0%)
|
176.46M
est: 122.42M (+44.1%)
|
55.61M
est: 137.85M (-59.7%)
|
146.13M
146.13M – 146.13M
+6.0% YoY
|
157.82M
157.82M – 157.82M
+8.0% YoY
|
| EPS |
0.48
est: 0.48 (+0.0%)
|
0.52
est: 0.49 (+6.1%)
|
0.59
est: 0.59 (+0.6%)
|
0.55
est.
|
0.52
est: 0.01 (+5,100.0%)
|
-0.45
est: -0.30 (-50.0%)
|
0.01
est: -0.30 (+103.3%)
|
-0.23
est: 0.02 (-1,250.0%)
|
0.01
est: 0.01 (+0.0%)
|
0.06
0.06 – 0.06
+500.0% YoY
|
0.07
0.07 – 0.07
+16.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 45.0K | 0.39% |
| 2 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 43.8K | 0.29% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dongmei Liu | Financial Director & Accounting Supervisor | — | female |
| Hong Bo Yu | Vice President | — | male |
| Hong Lin Zhang | Vice President | — | male |
| Shu Bo Wang | Vice President | — | male |
| Shuai Ma | Vice President & Board Secretary | — | male |
| Yang Guang | Vice President | — | male |
| Yangying Chen | Vice President | — | male |
| Zong Jiang Zhu | President | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300082.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
